Acriflavine: an efficient green fluorescent probe for sensitive analysis of aceclofenac in pharmaceutical formulations

Abstract

Acriflavine is a multipurpose drug that shows antibacterial, antiviral, antimalarial, and antifungal activities. The remarkable native fluorescence of acriflavine is exploited in analytical chemistry field as an efficient probe for analysis of pharmaceutical and biological compounds. The fluorescent probe action of acriflavine is based on the remarkable fluorescence turning-off via formation of ion-pair complexes with acidic drugs at a specific pH. Herein, the acidic drug aceclofenac is analysed for the first time using acriflavine as a fluorescent probe. Aceclofenac can form an ion-pair complex with acriflavine at pH 8.5, and hence it partially turns off the fluorescence intensity of acriflavine over a concentration range of 1–20 µg/mL. The fluorescence quenching was monitored at 502 nm following an excitation at 265 or 451 nm. The reaction stoichiometry between acriflavine and aceclofenac was found to be 1:1 using limiting logarithmic method. The type of quenching was confirmed to be static using Stern–Volmer plot. The method showed low values of quantitation limit (0.89 µg/mL) and detection limit (0.29 µg/mL). Moreover, the method was linear (r = 0.9999), accurate, precise (RSD < 1.7%), robust, and specific. The proposed method was successfully employed to analyse aceclofenac in its dosage forms with high %recovery (98–101%). Additionally, GAPI and AGREE approaches were used to guarantee the suggested techniques' greenness, and the findings showed an excellent level of greenness.

Supplementary Information

The online version contains supplementary material available at 10.1186/s13065-023-00979-2.

Introduction

Acriflavine (ACF) (Fig. 1) is a multipurpose drug that was used as an antibacterial drug before the discovery of penicillin [1, 2]. Besides its antibacterial activity, ACF is reported to have antiviral (against HIV), antimalarial, and anticancer activities [3–5]. Recently, it was proved that ACF has a powerful inhibitory effect on SARS-CoV-2 and hence it can be used for treatment of COVID-19 infection [1, 6]. Besides its biological and medicinal functions, it can be used as a selective fluorescent probe for analysis of acidic compounds such as ascorbic acid [7], sulfasalazine [8], and cefipime [9]. Its analytical applications are mainly based on its native fluorescence properties that could be exploited to be used as a fluorescent probe for analysis of various compounds. As a fluorescent probe, it can be quenched via the interaction of its basic function groups with acidic compounds (carboxylate or sulfonates), forming ion-pair complexes with lower fluorescent properties [7, 9, 10]. Therefore, its application could be extended to numerous acidic pharmaceutical compounds. In our study, aceclofenac was selected as a model example to study the interaction between ACF and acidic compounds for selective quantitative analysis of such compounds.

Fig. 1.

Chemical structures of aceclofenac drug and acriflavine (ACF) fluorescent probe

Aceclofenac, (2-[2-[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxyacetic acid, Fig. 1) is a mono carboxylic acid drug belonging to non-steroidal anti-inflammatory drugs (NSAID) [11]. It is widely used to relieve the painful inflammations associated with low back pain, ankylosing spondylitis, extraarticular rheumatism, scapulohumeral periarthritis, rheumatoid arthritis, and osteoarthritis [11, 12].

Numerous methods were reported for the analysis of aceclofenac in pharmaceutical formulations and/or biological fluids. The reported methods include spectrophotometric [13–16], spectrofluorometric [15], liquid chromatographic [17–20], capillary electrophoretic [21], and electrochemical [22, 23] methods. The spectrofluorimetric method [15] relied on monitoring the native fluorescence of aceclofenac in a phosphate buffer medium (pH 8) at 355 nm after excitation at 250 nm. The reported method had a narrow linear range of 2–8 µg/mL. Therefore, we aimed to develop a more sensitive method with a wider linear range for analysis of aceclofenac.

Herein, ACF fluorescent probe was used for the first time to analyse aceclofenac with a wider linear range (1–20 µg/mL) and a low detection limit (0.29 µg/mL). The merits of the proposed method involved simplicity, specificity, high accuracy, adequate sensitivity, and rapidity. In addition, the evolved method was employed to analyse aceclofenac in its pharmaceutical dosage form with low RSD (< 1.5%) and high recovery values (98–101%). The greenness of the developed method was estimated using Green Analytical Procedure Index (GAPI) and Analytical GREEnness (AGREE) approaches, which confirmed the excellent greenness of the fluorescent probe.

Experimental

Instrumentation

Fluorescent measurements of ACF before and after its interaction with aceclofenac target analyte were performed using Cary Eclipse fluorescence spectrophotometer. The spectrofluorimetric instrument is equipped with an Agilent Xenon flash lamp. The fluorescence quenching measurements of ACF sensor were monitored at 502 nm upon excitation at 265 or 451 nm. A smoothing factor of 20 was used for all measurements. The pH adjustments were performed using a Consort pH-meter (NV P-901, Belgium). The vortex mixer (IVM-300p, Taiwan) was used for homogenous mixing the solutions.

The comparison UV spectrophotometric method was performed by direct analysis of aceclofenac at 203 nm on the recorded zero order spectrum using methanol: water (50: 50, v/v) as the optimum solvent.

Materials and reagents

Aceclofenac (purity: 98.7%) was procured from SmithKline Beecham, (Egypt). Acriflavine (99.5% purity) was purchased from Eva Pharma Company (Cairo, Egypt). Bristaflam^® tablets (Batch number: 62000000056773), labeled to contain 100 mg of aceclofenac in each enteric coated tablet, was procured from local pharmacies, Egypt.

Boric acid and sodium hydroxide were acquired from Piochem Co, Egypt. Orthophosphoric acid and glacial acetic acid (99%), were purchased from EL-Nasr pharmaceutical company (ADWIC).

Britton Robinson buffer (BRB) solutions of pH ranging from 2.0 to 12.0 were prepared via mixing equal concentrations of acetic acid, boric acid, and phosphoric acid (40 mM each) and adjustment of the solutions’ pH using 0.2 M NaOH.

Standards

Aceclofenac standard solution (100 μg mL⁻¹) was prepared via dissolving 10.0 mg aceclofenac raw material in 100.0 mL ethanol. The acriflavine stock solution of 0.8 mM was performed via dissolution of 20.8 mg ACF in 100.0 mL distilled water. The prepared stock solution was further diluted to 8 × 10⁻³ mM by transferring 1.0 mL of ACF stock solution (0.8 mM) into a 100.0 mL volumetric flask and completing it to 100.0 mL with distilled water.

The working solution of ACF (8 × 10⁻⁴ mM) was daily prepared in dist. water to be employed for fluorescent measurements of aceclofenac samples.

Analysis of standards

Different quantities of aceclofenac within the concentration range (1.0–20.0 μg mL⁻¹) were placed into a series of 10-mL measuring flasks. Thereafter, one milliliter of the buffer (BRB solution adjusted at pH 8.5) and one milliliter of ACF solution (8 × 10⁻⁴ mM) were added, and the flasks were completed to the mark utilizing water, mixed well, and left for at least 2 min before fluorescence analysis. The remarkable decrease in the fluorescence intensity of ACF was then monitored at 502 nm (λ_ex = 265 or 451 nm), as shown in Figs. 2 and 3. All measurements were performed against blank for accurate analysis. The calibration curve was built by drawing the fluorescence intensity decrease (Fluorescent intensity of blank − fluorescent intensity of aceclofenac-ACF ion − pair complex) with respect to the final drug concentrations in μg mL⁻¹. Thereafter, the regression analysis was carried out.

Fig. 2 .

Fluorescent excitation (a, b) and emission (c) spectra of 8 × 10⁻⁷ M acriflavine (ACF) alone, and excitation (a′, b′) and emission (c′) spectra of 8 × 10⁻⁷ M ACF after reaction with 20 μg ml⁻¹ aceclofenac upon adjusting the emission wavelength at 502 nm and the excitation wavelength at 265 nm

Fig. 3 .

Fluorescent excitation (a, b) and emission (c) spectra of 8 × 10⁻⁷ M acriflavine (ACF) alone, and excitation (a′, b′) and emission (c′) spectra of 8 × 10⁻⁷ M ACF after reaction with 20 μg ml⁻¹ aceclofenac upon adjusting the emission wavelength at 502 nm and the excitation wavelength at 451 nm

Assay of aceclofenac in tablets

Ten Bristaflam^® tablets were weighed, completely crunched for quantitative determination of aceclofenac. A specified weight (equivalent to 10.0 mg aceclofenac) of the crunched tablets was accurately placed into 100-mL measuring flask. Thereafter, 70 mL of ethanol were added, and the flask was sonicated for 20 min before completing the flask to 100.0 mL with ethanol. The content of the flask was then filtered via a 0.45 μm syringe filter; the filtrate has been diluted with ethanol, and the procedure outlined in the “Analysis of standards” section was followed. Calculation of nominal content in tablets has been calculated from regression equation.

Estimation of quantum yield

The quantum yield of the effectively used ACF probe was estimated using the equation [24]:

$${\mathrm{\Phi }}_{\text{x}}={\mathrm{\Phi }}_{\text{st}}\times \left({\text{F}}_{\text{x}}/{\text{F}}_{\text{st}}\right)\times {\left({\mathrm{\eta }}_{\text{x}}/{\mathrm{\eta }}_{\text{st}}\right)}^2\times \left({\text{A}}_{\text{st}}/{\text{A}}_{\text{x}}\right)$$

where, in that order, the absorbance, the solvent refractive index, the integrated intensity of emission, and quantum yield were denoted as (A, F, η and Φ); η_x/η_st in aqueous solutions is equivalent to one. The subscript (x) denotes the unknown, whereas the subscript (st) denotes the reference fluorescein standard.

The reference fluorescein standard is prepared in 0.1 M NaOH, where its quantum yield is 0.93 [25]. The quantum yield of ACF was calculated using the above equation and its value was found to be 0.54 ± 0.03.

Results and discussion

Stepwise experimental optimisation

Turning off the remarkable fluorescence of ACF may be affected by various factors, which could sequentially be affected by the formed complex [aceclofenac-ACF; ion-association complex]. All parameters that could affect the formation of the complex, its stability or even the sensitivity of the method were studied to utilize the optimum parameters in each case.

Buffer pH and volume

The analysis of aceclofenac (10.0 µg/mL) using ACF probe was carried out at a pH range between 2.0 and 12.0 using the BRB buffer. The highest ΔF values were observed at a pH ranging from 8.0 to 9.0; hence, the pH 8.5 was selected as the optimum pH for this work, as illustrated in Fig. 4A, as it has a significant influence on the formation of a stable ion-pair complex. At pH values greater than 9.0, a significant decrease in the fluorescence intensity was observed. To study the effect of buffer volume, different quantities of the BRB solution (pH 8.5) ranging from 0.3 to 2.0 mL were studied, and it was found that highest ΔF are obtained when utilizing only 1.0 mL, as shown in Fig. 4B.

Fig. 4 .

The influence of stepwise experimental parameters variation on the quantification of aceclofenac (10.0 µg/mL) adopting fluorescence of 8 × 10⁻⁷ M acriflavine (ACF); where A pH of buffer (BRB), B volume of buffer, C volume of ACF (8 × 10⁻⁷ M), and D diluting solvents

Acriflavine volume

Different volumes of ACF (0.3–1.2 mL) were utilized to study the effect of ACF volumes on RFI. The maximum values of RFI were obtained upon using one milliliter as demonstrated in Fig. 4C.

Reaction medium

The effect of reaction medium was studied by investigating different solvents such as water, ethanol, methanol, and acetonitrile. Both ethanol and water exhibited high RFI upon analysis of aceclofenac, as demonstrated in Fig. 4D. On the other hand, both acetonitrile and methanol produced lower RFI values. Finally, we selected water as the solvent of choice because it rendered a relatively higher RFI values than ethanol and it is cheap, available, and safe.

Explanatory mechanism of the reaction between aceclofenac and ACF

Stoichiometry of the reaction between aceclofenac and ACF

The alternate measurement of the ΔF of the reaction product at increasing conc. of either aceclofenac or ACF was done using a limiting logarithmic approach. As shown in Fig. 5, the log (RFI) vs. log [ACF] and log (RFI) vs. log [aceclofenac] plots both showed straight lines with slope values of 1.045 and 0.904, respectively. It was determined that the reaction's molar reactivity was 1.045/0.904, meaning that the ratio of ACF to aceclofenac was 1:1. The ratio may be calculated owing to aceclofenac's single carboxylic group. Aceclofenac's negatively charged carboxylate group and the ACF's positively charged nitrogen atom interacted at a particular pH. So, the electrostatic forces participated in the creation of an ion-association complex as illustrated in Fig. 6.

Fig. 5 .

Stoichiometry of the fluorimetric interaction between aceclofenac and acriflavine (ACF) using limiting logarithmic method where: A log [aceclofenac] against log RFI, B log [ACF] against log RFI

Fig. 6.

Schematic illustration of the reaction pathway between aceclofenac drug and aciflavine (ACF) to form the ion-associated complex

Mechanism of turning off the fluorescence of fluorescent probe (ACF) in response to aceclofenac

Turning off the fluorescence of ACF is mainly due to formation of ion-pair complex with acidic compounds (Aceclofenac). The cause of quenching may rely on the following possible interactions: collisional quenching, excited-state interreactions, molecular rearrangement, and ground-state complex formations. It is an important issue to assess the quenching type in our study to inspire the mechanism of quenching. Stern–Volmer curves are built up using the equation:

$${\text{F}}_{\text{o}}/\text{F}=1+{\text{K}}_{\text{SV}}[\text{C}].$$

where [C] is the drug's molar concentration, F and F_o are ACF’s relative fluorescent intensities when the drug is present and absent, respectively. K_SV stands as the Stern–Volmer constant. All results of the proposed method were conducted after adjusting excitation wavelength at 451 nm.

By graphing F_o/F against [C], the Stern–Volmer plots were created, and the linearity of the plots (r = 0.993, 0.992, and 0.99) predicts whether dynamic or static quenching will occur. Also, by creating Stern–Volmer graphs at three different temperatures, the temperature dependency was examined (Fig. 7).

Fig. 7.

Stern–Volmer graphs for aceclofenac at 303, 313, and 323 K

The K_SV in Table 1 decreases as temperature rises, which is a sign of static quenching. We ultimately decided that ACF and aceclofenac create a non-fluorescent complex, and its stability is decreased upon increasing temperatures. The following equation was used to compute the bimolecular quenching constants (K_q), which represent the fluorescence efficiency:

$${\text{K}}_{\text{q}}={\text{K}}_{\text{SV}}/{\text{t}}_0,$$

where the luminescence lifetime of ACF is 5 × 10⁻⁹ s, so K_q was found to be 4.6–5.6 × 10¹² l mol⁻¹ s⁻¹.

Table 1.

Stern–Volmer parameters for the complex-formation reaction between aceclofenac and the fluorescent probe ACF

Temperature	30 °C (303 K)	40 °C (313 K)	50 °C (323 K)
Correlation coefficient (r)	0.993	0.992	0.990
Stern–Volmer quenching constant Ksv (l mol−1) KSV = slope	0.028 × 106	0.026 × 106	0.023 × 106
T0 (florescence lifetime)	5 × 10–9	5 × 10–9	5 × 10–9
Bimolecular quenching constant Kq = KSV/t0	5.6 × 1012	5.2 × 1012	4.6 × 1012

Figures 8 and 9 show the gradual decrease in the fluorescence intensity of ACF probe upon addition of increasing conc. of aceclofenac after excitation at 265 and 451 nm, respectively. This linear decrease in fluorescence intensity of ACF was employed for efficient quantitative assay of aceclofenac in raw material and pharmaceutical tablets.

Fig. 8.

Quenching of the fluorescence emission of ACF in quantitative manner upon addition of increasing concentrations of aceclofenac (ACL) after excitation at 265 nm. From red to green: 0.0, 1.0, 3.0, 10.0, 14.0, 16.0, 18.0, 20.0 µg/mL of aceclofenac

Fig. 9.

Turning-off the fluorescence emission of Acriflavine in quantitative manner upon addition of increasing concentrations of aceclofenac (ACL) after excitation at 451 nm. From red to blue (0.0, 1.0, 3.0, 10.0, 14.0, 16.0, 18.0, 20.0 µg/mL aceclofenac)

Validation

The evolved fluorescent method was fully validated according to the ICH Q2 (R1) guidelines [26]. All validation measurements were performed after adjusting the excitation wavelength at 451 nm.

The linearity was confirmed by the high value of correlation coefficient (r = 0.9999) for aceclofenac when the RFI was plotted against aceclofenac concentration. The method was rectilinear over the range of 1.0–20 µg/mL for aceclofenac as demonstrated in Table 2.

Table 2.

Analytical data for the spectrofluorometric assay of aceclofenac using the acriflavine (ACF) as a fluorescent probe

Parameter	Range/value
Excitation and emission wavelength (λex/em)	451/502 nm
Concentration range	1.0–20.0 µg/mL
Correlation coefficient	0.9999
Intercept ± Sa	− 4.39 ± 2.99
Slope ± Sb	33.61 ± 0.22
Standard deviation of residuals	3.98
Limit of detection	0.29 µg/mL
Limit of quantification	0.89 µg/mL
% Relative standard deviation	0.93
%Error	0.35

S_a: standard deviation of intercept; S_b: standard deviation of slope

Both detection and quantitation limits were calculated according to the ICH Q2 (R1) recommendations [26] using the following equations, LOD = 3.3 S_a/b and LOQ = 10 S_a/b, in which LOD refers to the limit of detection, LOQ refers to the limit of quantitation, "S_a" denotes standard deviation of the intercept, and "b" denotes the slope of the calibration curve.

The results in Table 2 indicates low values of LOD (0.29 µg/mL) and LOQ (0.89 µg/mL), which are suitable to assay aceclofenac in its pharmaceutical dosage form.

To assess the accuracy of the developed method, a comparison spectrophotometric method [16] was performed to compare the results with those obtained from our proposed method. The obtained results (Table 3) demonstrated that no significant difference between the proposed and the comparison methods by applying t- and F-tests [27].

Table 3.

Comparison between the proposed spectrofluorometric method and the reported spectrophotometric one relying on the % recoveries of aceclofenac in pure form

Proposed methodd			Reported method [16]
Conc. taken (µg/mL)	Conc. found (µg/mL)	% recoverya ± SD	% recoverya ± SD
1.0	0.99	99.40 ± 1.12	97.70 ± 1.35
3.0	2.96	98.60 ± 0.78	98.320 ± 1.79
10.0	9.95	99.50 ± 1.22	101.02 ± 1.31
14.0	14.22	101.57 ± 1.54	99.63 ± 1.43
16.0	16.05	100.31 ± 0.72
18.0	17.91	99.50 ± 0.77
20.0	19.92	99.59 ± 0.34
$\overline{\text{X}}$ ± SD = 99.78 ± 0.93			99.17 ± 1.47
t-test = 0.86 (2.26)b
F-value = 2.5 (8.94)c

^aMean recovery of three separate determinations

^bTabulated t-value at (P = 0.05) [27]

^cTabulated F-value at (P = 0.05) [27]

^dAll results of the proposed method were conducted after adjusting excitation wavelength at 451 nm

Repeatability and intermediate precision of the developed spectrofluorimetric method were employed by conducting triplicate assays of aceclofenac using 3 different concentrations (10.0, 14.0, 18.0 µg/mL) in one day and in three successive days, respectively. Small values of the relative standard deviations (RSD) ensured the high precision of the developed spectrofluorimetric method (Table 4).

Table 4.

Precision data obtained via spectrofluorometric determination of aceclofenac utilizing acriflavine (ACF) as a fluorescent sensor

Parameters		Aceclofenac concentration (µg/mL)
		10.0	14.0	18.0
Intra-day	% Recoverya	99.50	102.49	98.09
		101.17	101.57	98.26
		98.80	99.48	99.50
	Mean recovery ± RSD	99.82 ± 1.22	101.18 ± 1.53	99.62 ± 0.78
	% Error	0.70	0.88	0.45
Inter-day	% Recoverya	98.31	101.57	99.50
		99.50	102.96	97.98
		101.29	99.62	100.87
	Mean recovery ± RSD	99.70 ± 1.50	101.38 ± 1.66	99.45 ± 1.45
	% Error	0.87	0.96	0.84

^aMean value of three individual determinations

All measurements were performed after excitation at 451 nm

The specificity of the developed method was confirmed when the method was applied to analyse aceclofenac in its pharmaceutical preparation (Bristaflam^® tablets) where no interferences from the tablets’ excipients were observed.

The robustness of the developed method was confirmed by assessing the influence of small deliberate variation in method parameters on the analytical performance of the developed sensor. These parameters involved pH of the buffer, volume of the buffer, and the volume of reagent. The results indicated that these small changes have no significant effect on the performance of the proposed methods as illustrated in Additional file 1: Table S1.

Application

The developed fluorescence-based spectroscopic method was utilized to assay aceclofenac in its tablet dosage form. The results were statistically compared with the reported spectrophotometric method [16] by employing student’s t-test and variance ratio F-test [27]. The relevance and agreement of the results ensured the aptness of application of the developed method in quality control of aceclofenac in its tablets as demonstrated in Table 5.

Table 5.

Comparison between the proposed spectrofluorometric method and the reported spectrophotometric for the analysis of aceclofenac in tablet dosage form

Drug (aceclofenac)	Proposed fluorimetric methode			Comparison method [16]
	Conc. taken (µg/mL)	Conc. found (µg/mL)	% Recoveryb	% Recoveryb
Bristaflam® tableta	10.0	9.80	98.01	98.29
	14.0	14.09	100.62	101.33
	16.0	15.76	98.50	99.59
$\overline{\text{X}}$ ± SD	99.04 ± 1.38			98.94 ± 1.53
t-test	0.58 (2.78)c
F-value	1.21 (19.0)d

^aBristaflam^® labeled to contain 100 mg of aceclofenac in each tablet

^bMean recovery of three separate determinations

^cTabulated t-value at (P = 0.05) [25]

^dTabulated F-value at (P = 0.05) [25]

^eAll results of the proposed method were conducted after adjusting excitation wavelength at 451 nm

Greenness appraisal

The greenness of the developed method was performed using Green Analytical Procedure Index (GAPI) and Analytical GREEnness (AGREE) approaches.

GAPI is a pioneering technique that could assess the greenness of the evolved method with performed analytical procedure dependent on fifteen features from sample collection to sample analysis. In accordance with the degree of environmental effect on various parameters, five pentagrams were drawn and colored (each pictogram is divided into 3 or 4 sections) using the GAPI approach, as shown in Fig. 10. A high environmental impact is guaranteed by the color red, a medium environmental effect is conveyed by yellow, and a low environmental impact is indicated by green [28]. The method became more environmentally friendly and sustainable as the number of green-shaded areas increased. Seven green sections were displayed in Fig. 10. This manifestation affirmed the sustainability of the suggested method and supported its suitability for utilization in routine pharmaceutical analysis.

Fig. 10.

GAPI and AGREE approaches for greenness appraisal of the developed method

AGREE is an innovative way to assess how environmentally friendly the suggested technique is. The evaluation of AGREE was conducted using the 12 Green Analytical Chemistry (GAC) principles. Twelve portions, each representing one of different GAC principles, make up the perimeter of the clock-like-AGREE graph. The pictogram's unique color (ranging from dark green (1.0) to red (0.0)) represents each parameter's score [29]. The performance's overall color and computed score is shown in the center of the graph. The suggested strategy has a green core color with score of 0.82, which indicates a minimal ecological impact of the evolved method (Fig. 10).

Comparison of the proposed method with the previously reported methods for the analysis of aceclofenac

Many criteria were considered when comparing the performance of the ACF as a sensing probe for determination of aceclofenac with the other reported ones. First, the sensitivity factor was investigated; the executed approach was found to be 2–103 times more sensitive than some published methods [13–16, 21, 23]. Despite the fact that other reported methods [17–20, 22] were more sensitive than the evolved method, the ecological part that employed green chemistry in the evolved method gave it a competitive advantage. In contrast to previously published methods, all solvents and reagents utilised in the suggested approach were safe and eco-friendly, causing no negative impacts on the environment. Hazardous, toxic, explosive solvents and reagents were employed in significant quantities in previously published methods [13–20, 22, 23]. Furthermore, time is a crucial consideration when developing a new quantitative method. ACF probe is characterized by its ultra-fast determination, in contrast to these methods [17–20] which are time consuming and need lengthy conditioning, washing, and analysis. Only one spectrofluorometric approach [15] for quantification of aceclofenac was described, but it was less sensitive and had a limited linear range when compared to the evolved method. Additional file 1: Table S2 summaries the comparison between the proposed technique and the other published ones. The findings confirmed the superiority of the proposed method over the previously published methods.

Conclusion

A selective ACF fluorescent probe was developed for simple, precise, and rapid analysis of aceclofenac drug for the first time. The reaction mechanism between aceclofenac and ACF was demonstrated efficiently which shows 1:1 ion-pair complex formation at pH 8.5. The quenching of ACF by aceclofenac was found to be static because the increase in temperature was associated with a decrease in Stern–Volmer constants. The fluorescence quenching was monitored at 502 nm following an excitation at 265 or 451 nm. In addition, the developed fluorescent method was fully validated and efficiently applied to assay aceclofenac in both raw material and dosage form with low RSD (< 1.5%) and high percent recovery (98–101%). The GAPI and AGREE approaches proved the remarkable degree of greenness of the evolved method. High sensitivity, simplicity, rapidity, and sustainability are the key features of the sensor system. This approach is more consistent than the previous published research and is highly recommended for utilization in quality control laboratories because no prior extraction or sample treatment was accomplished.

Abbreviations

A

Absorbance

ACF

Acriflavine

AGREE

The analytical greenness calculator

b

Slope

BRB

Britton Robinson buffer

C

Concentration

COVID-19

Corona virus disease 2019

λ_ex

Excitation wavelength

λ_em

Emission wavelength

F

Fluorescence

Φ

Quantum yield

GAC

Green analytical chemistry

GAPI

Green analytical procedure index

HIV

Human immunodeficiency virus

ICH

International Council on Harmonisation

K_SV

Stern–Volmer constant

Kq

Bimolecular quenching constant

LC–MS/MS

Liquid chromatography–tandem mass spectrometry

LOD

Limit of detection

LOQ

Limit of quantification

η

Solvent refractive index

r

Correlation coefficient

RFI

Relative fluorescence intensity

RP-HPLC

Reversed-phase high-performance liquid chromatography

RSD

Relative standard deviation

S_a

Standard deviation of intercept

S_b

Standard deviation of slope

SD

Standard deviation

st

The standard

t₀

Luminescence lifetime

x

The unknown sample

Author contributions

AAE-M: conceptualization, investigation, methodology, data analysis, validation, writing the original draft. AMZ: conceptualization, methodology, visualization, resources, project administration, and writing—review and editing.

Availability of data and materials

The datasets generated and/or analysed during the current study are available from the corresponding author upon a reasonable request.

Declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.